AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy

Published:2012-02 Issue:6 Volume:287 Page:3885-3897
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ohashi Yoshimi,Iijima Hiroshi,Yamaotsu Noriyuki,Yamazaki Kanami,Sato Shigeo,Okamura Mutsumi,Sugimoto Kenji,Dan Shingo,Hirono Shuichi,Yamori Takao

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference64 articles.

1. Small-molecule inhibitors of protein-protein interactions;Berg;Curr. Opin. Drug Discov. Devel.,2008

2. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces;Wells;Nature,2007

3. Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy. The investigation of p53-MDM2 interaction and its inhibition by small molecules;Lauria;Curr. Med. Chem.,2010

4. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy;Azmi;J. Cell Physiol.,2009

5. ARF proteins. Roles in membrane traffic and beyond;D'Souza-Schorey;Nat. Rev. Mol. Cell Biol.,2006

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Arf1 Inhibitors Drive Cancer Stem Cell Aging and Potentiate Anti‐Tumor Immunity;Advanced Science;2024-09-03

2. Golgi apparatus targeted therapy in cancer: Are we there yet?;Life Sciences;2024-09

3. Membrane trafficking alterations in breast cancer progression;Frontiers in Cell and Developmental Biology;2024-03-12

4. Exploring Retrograde Trafficking: Mechanisms and Consequences in Cancer and Disease;Traffic;2024-02

5. The Golgi Apparatus as an Anticancer Therapeutic Target;Biology;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3